Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $167.33.
Several research firms have recently weighed in on ACLS. Bank of America lifted their target price on shares of Axcelis Technologies from $125.00 to $150.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 10th. Needham & Company LLC reissued a “hold” rating on shares of Axcelis Technologies in a research note on Friday, August 2nd. Craig Hallum raised their target price on Axcelis Technologies from $130.00 to $174.00 and gave the stock a “buy” rating in a research report on Friday, July 12th. B. Riley lowered their price target on Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a report on Friday, August 2nd. Finally, Benchmark reduced their price objective on Axcelis Technologies from $180.00 to $175.00 and set a “buy” rating for the company in a research note on Friday, August 2nd.
Get Our Latest Report on Axcelis Technologies
Axcelis Technologies Stock Performance
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The semiconductor company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.18. Axcelis Technologies had a return on equity of 27.35% and a net margin of 21.54%. The business had revenue of $256.51 million during the quarter, compared to analyst estimates of $250.06 million. During the same quarter in the prior year, the firm posted $1.86 earnings per share. The company’s revenue was down 6.4% on a year-over-year basis. Sell-side analysts predict that Axcelis Technologies will post 6.05 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, Director Jorge Titinger sold 6,086 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $109.98, for a total value of $669,338.28. Following the completion of the sale, the director now owns 5,891 shares of the company’s stock, valued at approximately $647,892.18. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 1.43% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in ACLS. GAMMA Investing LLC grew its holdings in Axcelis Technologies by 109.4% in the 1st quarter. GAMMA Investing LLC now owns 266 shares of the semiconductor company’s stock valued at $30,000 after buying an additional 139 shares during the last quarter. Signaturefd LLC increased its position in Axcelis Technologies by 348.9% during the second quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock worth $30,000 after acquiring an additional 164 shares during the period. Blue Trust Inc. raised its stake in Axcelis Technologies by 223.8% during the 2nd quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock valued at $39,000 after purchasing an additional 188 shares during the last quarter. Ashton Thomas Private Wealth LLC acquired a new stake in Axcelis Technologies in the 2nd quarter worth $39,000. Finally, Isthmus Partners LLC increased its holdings in shares of Axcelis Technologies by 87.3% during the 2nd quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company’s stock worth $47,000 after purchasing an additional 15,507 shares during the period. 89.98% of the stock is owned by institutional investors.
About Axcelis Technologies
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
Featured Stories
- Five stocks we like better than Axcelis Technologies
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- Insider Buying Explained: What Investors Need to Know
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- Comparing and Trading High PE Ratio Stocks
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.